Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.66)
# 775
Out of 5,072 analysts
83
Total ratings
40.74%
Success rate
10.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $6.80 | +958.82% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $10.44 | +244.99% | 5 | Oct 28, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $400 → $540 | $601.03 | -10.15% | 4 | Oct 15, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $16.53 | +371.87% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $9.47 | +111.19% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.60 | +465.22% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.58 | +153.16% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $4.02 | +1,840.30% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $49.55 | +192.63% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $25.52 | +99.84% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.43 | +319.58% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $18.55 | +158.76% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $66.16 | +40.57% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $28.00 | +167.86% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $65.69 | +59.84% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $41.45 | -10.74% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $3.80 | +584.21% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.70 | +3,894.29% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $46.03 | +110.73% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $188.54 | +43.21% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.39 | +255.31% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.17 | +383.56% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.02 | +130.50% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.37 | +28.07% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.30 | +1,328.57% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $5.52 | +3,160.87% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $3.34 | +349.10% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.36 | +198.51% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $42.16 | +89.75% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $34.22 | +171.77% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $23.70 | +140.51% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.08 | +846.33% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $90.07 | -61.14% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.93 | +524.69% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.86 | +1,674.85% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $68.15 | +5.65% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $9.99 | +400.50% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.36 | +2,841.18% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.36 | +4,900.00% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $16.14 | +2,502.23% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $73.13 | +5.29% | 1 | Jul 31, 2020 |
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $6.80
Upside: +958.82%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $10.44
Upside: +244.99%
Madrigal Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $400 → $540
Current: $601.03
Upside: -10.15%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $16.53
Upside: +371.87%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $9.47
Upside: +111.19%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.60
Upside: +465.22%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.58
Upside: +153.16%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $4.02
Upside: +1,840.30%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $49.55
Upside: +192.63%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $25.52
Upside: +99.84%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.43
Upside: +319.58%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $18.55
Upside: +158.76%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $66.16
Upside: +40.57%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $28.00
Upside: +167.86%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $65.69
Upside: +59.84%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $41.45
Upside: -10.74%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $3.80
Upside: +584.21%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.70
Upside: +3,894.29%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $46.03
Upside: +110.73%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $188.54
Upside: +43.21%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.39
Upside: +255.31%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.17
Upside: +383.56%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.02
Upside: +130.50%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.37
Upside: +28.07%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.30
Upside: +1,328.57%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $5.52
Upside: +3,160.87%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $3.34
Upside: +349.10%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.36
Upside: +198.51%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $42.16
Upside: +89.75%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $34.22
Upside: +171.77%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $23.70
Upside: +140.51%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.08
Upside: +846.33%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $90.07
Upside: -61.14%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.93
Upside: +524.69%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.86
Upside: +1,674.85%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $68.15
Upside: +5.65%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $9.99
Upside: +400.50%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.36
Upside: +2,841.18%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.36
Upside: +4,900.00%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $16.14
Upside: +2,502.23%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $73.13
Upside: +5.29%